Evidence map›Paper›PMID 32132174›Full record

ArticleThe Journal of biological chemistry2020

Development of a novel β-1,6-glucan-specific detection system using functionally-modified recombinant endo-β-1,6-glucanase.

Daisuke Yamanaka, Kazushiro Takatsu, Masahiro Kimura, Muthulekha Swamydas, Hiroaki Ohnishi, Takashi Umeyama, Fumitaka Oyama, Michail S Lionakis, Naohito Ohno

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.3field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Interaction Between Dendritic Cells andFrontiers in cellular and infection microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Daisuke YamanakaLaboratory for Immunopharmacology of Microbial Products, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo 192-0392, Japan; Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology, NIAID, National Institutes of Health, Bethesda, Maryland 20892. Electronic address: ymnkd@toyaku.ac.jp.
Kazushiro TakatsuLaboratory for Immunopharmacology of Microbial Products, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo 192-0392, Japan.
Masahiro KimuraDepartment of Chemistry and Life Science, Kogakuin University, Hachioji, Tokyo 192-0015, Japan; Research Fellow of Japan Society for the Promotion of Science (DC2), Koujimachi, Chiyoda-ku, Tokyo 102-0083, Japan.
Muthulekha SwamydasFungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology, NIAID, National Institutes of Health, Bethesda, Maryland 20892.
Hiroaki OhnishiDepartment of Laboratory Medicine, Kyorin University School of Medicine, Mitaka, Tokyo 181-8611, Japan.
Takashi UmeyamaDepartment of Chemotherapy and Mycoses, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo 162-8640, Japan.
Fumitaka OyamaDepartment of Chemistry and Life Science, Kogakuin University, Hachioji, Tokyo 192-0015, Japan.
Michail S LionakisFungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology, NIAID, National Institutes of Health, Bethesda, Maryland 20892.
Naohito OhnoLaboratory for Immunopharmacology of Microbial Products, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo 192-0392, Japan.
National Institutes of Health · USKogakuin University · JPTokyo University of Pharmacy and Life Sciences · JPKyorin University · JPNational Institute of Infectious Diseases · JP

Funding

Immunopathogenesis of Fungal InfectionsZIAAI001175 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI LIONAKIS, MICHAIL · 2012 to 2025
$23.9M
Intramural NIH HHS ZIA AI001175
6 · The paper itself

Abstract

β-1,3-d-Glucan is a ubiquitous glucose polymer produced by plants, bacteria, and most fungi. It has been used as a diagnostic tool in patients with invasive mycoses via a highly-sensitive reagent consisting of the blood coagulation system of horseshoe crab. However, no method is currently available for measuring β-1,6-glucan, another primary β-glucan structure of fungal polysaccharides. Herein, we describe the development of an economical and highly-sensitive and specific assay for β-1,6-glucan using a modified recombinant endo-β-1,6-glucanase having diminished glucan hydrolase activity. The purified β-1,6-glucanase derivative bound to the β-1,6-glucan pustulan with a

Indexed as

Animalsbeta-GlucansBiosensing TechniquesCandidaEnzyme AssaysFemaleFungal PolysaccharidesGlycoside HydrolasesMiceMice, Inbred C57BLMice, Inbred ICRPolysaccharidesRecombinant Proteinsbeta-1,6-glucanbeta-Glucansendo-1,6-beta-glucanaseFungal PolysaccharidesGlycoside HydrolasesPolysaccharidespustulanRecombinant Proteinsanimal modelCandida albicansdeep mycosisendo-β-1,6-glucanasefungiglycobiologyglycoside hydrolaseinfectious diseaseβ-1,3-D-glucanβ-1,6-glucan

Identifiers

PMID32132174
PMCPMC7170528
OpenAlexW3010636143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.